Sinemet

DRUG3 trials

Sponsors

Northwestern University, Impax Laboratories, LLC, Acorda Therapeutics

Conditions

Acute PainAdvanced Parkinson's DiseaseParkinson's Disease

Phase 1

Pharmacokinetic Study of CVT-301 (Levodopa Inhalation Powder)

CompletedNCT03887884

Acorda TherapeuticsParkinson's Disease

Start: 2019-03-05End: 2019-06-28Updated: 2019-08-02

Phase 2

Efficacy of Co-administration of an NSAID With a Dopamine Agonist In Healthy Subjects

WithdrawnNCT02116790

Northwestern UniversityAcute Pain

Start: 2014-05-31End: 2015-01-31Updated: 2014-10-10

A Study to Assess the PK and Pharmacodynamics of IPX203 in Subjects With Advanced Parkinson's Disease

CompletedNCT03007888

Impax Laboratories, LLCAdvanced Parkinson's Disease

Start: 2016-11-14End: 2017-08-01Updated: 2022-06-06

Related Papers

Pharmacokinetics of Inhaled Levodopa Administered With Oral Carbidopa in the Fed State in Patients With Parkinson's Disease

Clinical Therapeutics2020-05-3019 citations